Photothermal amplified multizyme activity for synergistic photothermal-catalytic tumor therapy.

J Colloid Interface Sci

Faculty of Chemistry, Northeast Normal University, 5268 Renmin Street, Changchun, Jilin 130024, PR China. Electronic address:

Published: February 2025

Nano-enzymatic catalytic therapy has been widely explored as a promising tumor therapeutic method with specific responsiveness to the tumor microenvironment (TME). However, the inherent lower and simplex catalytic efficiency impairs their anti-tumor efficacy. Therefore, developing novel nanozymes with relatively high and multiple catalytic characteristics, simultaneously enhancing the enzyme-like activity of nanozymes using the proper method, photothermal promoted catalytic property, is a reliable way. In this paper, we report a manganese oxide/nitrogen-doped carbon composite nanoparticles (MnO-N/C NPs) with multi-enzyme mimetic activity and photothermal conversional effect. The peroxidase (POD)-like/oxidase (OXD)-like/catalase (CAT)-like activity of MnO-N/C nanozymes was accelerated upon exposure to an 808 nm NIR laser. In vitro and in vivo results proved that the MnO-N/C NPs shown excellent magnetic resonance imaging (MRI) guided synergistic photothermal-enhanced catalytic treatment and photothermal therapy of liver cancer. The photothermal enhanced multi-enzyme activity maximizes the efficacy of catalytic and photothermal therapy while reducing harm to healthy cells, thereby offering valuable insights for the development of next-generation photothermal nanozymes to enhance tumor therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcis.2024.09.223DOI Listing

Publication Analysis

Top Keywords

tumor therapy
8
mno-n/c nps
8
photothermal therapy
8
photothermal
7
catalytic
6
activity
5
therapy
5
photothermal amplified
4
amplified multizyme
4
multizyme activity
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!